Valuation: Tandem Diabetes Care, Inc.

Capitalization 1.02B 878M 818M 761M 1.4B 88.11B 1.57B 9.88B 3.73B 41.31B 3.84B 3.76B 152B P/E ratio 2025 *
-6.48x
P/E ratio 2026 * -26.9x
Enterprise value 830M 712M 664M 618M 1.14B 71.51B 1.27B 8.02B 3.03B 33.53B 3.11B 3.05B 123B EV / Sales 2025 *
0.83x
EV / Sales 2026 * 0.68x
Free-Float
99.23%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.80%
1 week-3.72%
Current month-19.47%
1 month-26.44%
3 months-8.42%
6 months-57.48%
Current year-58.33%
More quotes
1 week 14.87
Extreme 14.87
16.3
1 month 14.87
Extreme 14.87
21.18
Current year 14.87
Extreme 14.87
38.28
1 year 14.87
Extreme 14.87
47.6
3 years 13.82
Extreme 13.82
70.8
5 years 13.82
Extreme 13.82
155.86
10 years 2.14
Extreme 2.14
155.86
More quotes
Manager TitleAgeSince
Chief Executive Officer 69 28/02/2019
Director of Finance/CFO 52 31/12/2017
Chief Operating Officer 61 20/06/2024
Director TitleAgeSince
Director/Board Member 65 30/06/2013
Director/Board Member 69 31/05/2019
Chairman 64 28/02/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.80%-3.72%-64.78%-72.46% 1.02B
+3.27%-5.70%+24.41%+16.33% 210B
+0.17%-0.11%+10.60%+2.18% 115B
-0.14%-0.35%+31.49%+109.52% 57.06B
-0.82%+2.63%-22.07%-22.93% 51.85B
-0.05%+3.04%-12.03%+43.01% 42.31B
-0.49%+0.92%-24.00%+9.28% 32.98B
-1.16%-1.23%-14.43%+11.71% 24.3B
+0.63%-0.80%+0.33%+8.79% 22.09B
-1.32%-6.55%+8.46%-41.86% 21.75B
Average -0.27%-2.10%-6.20%+6.36% 57.77B
Weighted average by Cap. +1.02%-3.64%+9.45%+17.92%
See all sector performances

Financials

2025 *2026 *
Net sales 1B 861M 802M 746M 1.38B 86.43B 1.54B 9.69B 3.66B 40.52B 3.76B 3.69B 149B 1.11B 952M 887M 825M 1.52B 95.57B 1.7B 10.72B 4.05B 44.81B 4.16B 4.08B 165B
Net income -164M -141M -131M -122M -225M -14.12B -251M -1.58B -598M -6.62B -615M -602M -24.33B -44.27M -37.98M -35.39M -32.93M -60.75M -3.81B -67.83M -428M -161M -1.79B -166M -163M -6.57B
Net Debt -193M -165M -154M -143M -264M -16.6B -295M -1.86B -703M -7.78B -723M -708M -28.61B -274M -235M -219M -204M -376M -23.57B -419M -2.64B -998M -11.05B -1.03B -1.01B -40.63B
More financial data * Estimated data
Logo Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Employees
2,650
More about the company
Date Price Change Volume
18/07/25 15.00 $ -2.34% 428,381
17/07/25 15.36 $ -2.48% 1,755,952
16/07/25 15.75 $ +3.62% 1,832,506
15/07/25 15.20 $ -3.49% 2,145,980
14/07/25 15.75 $ +1.03% 1,663,298

Delayed Quote Nasdaq, July 18, 2025 at 05:18 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
15.36USD
Average target price
31.45USD
Spread / Average Target
+104.75%
Consensus

Quarterly revenue - Rate of surprise